Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo

Nitric Oxide - Biology and Chemistry

Volumn 4, Issue 2, 2000, Pages 85-93

  Conner, Elaine M ^a   Aiko, Satoshi ^a   Fernandez, Mercedes ^a   Battarbee, Harold D ^a   Gray, Laura ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Blood flow; Colitis; Colon; Inflammatory bowel disease; Intestine; Nitric oxide

Indexed keywords

N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ARTICLE; COLITIS; COLON DISEASE; FEMALE; HEMODYNAMIC PARAMETERS; INFLAMMATORY DISEASE; INTESTINE BLOOD FLOW; NONHUMAN; ORGAN BLOOD FLOW; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0034113602     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.2000.0270     Document Type: Article

References (36)

1. Ferraz J. G. P., Tigley A., Wallace J. L. Paradoxical effects of l-arginine on gastric mucosal integrity. Eur. J. Pharmacol. 260:1994;107-111
2. Lopez-Belmonte J., Whittle B. J. R., Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br. J. Pharmacol. 108:1993;73-78
3. Aiko S., Grisham M. B. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology. 109:1995;142-150
4. Aiko S., Fuseler J., Grisham M. B. Effects of nitric oxide synthase inhibition or sulphasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats. J. Pharm. Exp. Ther. 284:1998;722-727
5. Grisham M. B., Special R. B., Zimmerman T. E. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of granulomatous colitis. J. Pharm. Exp. Ther. 271:1994;1114-1121
6. Hogaboam C. M., Jacobson K., Collins M., Blennerhassett M. G. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am. J. Physiol. 268:1995;G673-G684
7. Ribbons K. A., Currie M. G., Connor J. A., Manning P. T., Allen P. C., Didier P., Ratterree M. S., Clark D. A., Miller M. J. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J. Pharmacol. Exp. Ther. 280:1997;1008-1015
8. Casadevall M., Panes J., Pique J. M., Marroni N., Bosch J., Whittle B. J. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology. 18:1993;628-634
9. Ohta M., Tanoue K., Tamawski A. S., Pai R., Itani R. M., Sander F. C., Sugimachi K., Sarfeh I. J. Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: A key to increased susceptibility to damage? Gastroenterology. 112:1997;1920-1930
10. Pizcueta M. P., Pique J. M., Bosch J., Whittle B. J., Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br. J. Pharmacol. 105:1992;184-190
11. Martin P., Xu D., Niederberger M., Weigert A., Tsai P., St. John J., Gines P., Schrier R. Upregulation of endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats. Am. J. Physiol. 270:1996;F494-F499
12. Niederberger M., Martin P. Y., Gines P., Morris K., Tsai P., Xu L., McMurtry I., Schrier R. W. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology. 109:1995;1624-1630
13. Miller M. J. S., Sadowska-Krowicka H., Chotinaruemol S., Kakkis J. L., Clark D. A. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J. Pharm. Exp. Ther. 264:1993;11-16
14. Rachmilewitz D., Karmeli F., Okon E., Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut. 37:1995;247-255
15. Pfeiffer S., Leopold E., Schmidt K., Brunner F., Mayer B. Inhibition of nitric oxide synthesis by NG-nitro-l-arginine methyl ester (l-NAME): Requirement for bioactivation to the free acid, NG-nitro-l-arginine. Br. J. Rheumatol. 118:1996;1433-1440
16. Mitchell J. A., Kohlhaas K. L., Sorrentino R., Warner T. D., Murad F., Vane J. R. Induction by endotoxin of nitric oxide synthase in the rat mesentery: Lack of effect on action of vasoconstrictors. Br. J. Pharmacol. 109:1993;265-270
17. Rees D. D., Palmer R. M. J., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752
18. G-nitro-l-arginine. Br. J. Pharmacol. 118:1996;1433-1440
19. G-nitro-l-arginine act as prodrugs in the inhibition of inducible nitric oxide synthase. Moncada S., Freelisch M., Busse R., Higgs E. A. The Biology of Nitric Oxide 4: Enzymology, Biochemistry and Immunology. 1995;4-7 Portland Press, London
20. Medeiros M. V., Binhara I. M., Moreno Junior H., Zatz R., De Nucci G., Antunes E. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats. Eur. J. Pharmacol. 285:1995;109-114
21. O'Brien C., Kelly P. A., Ritchie I. M. Effect of chronic inhibition of nitric oxide synthase on ocular blood flow and glucose metabolism in the rat. Br. J. Opthamol. 81:1997;68-71
22. Guyton A. C. Medical Physiology. 1991;Saunders, Philadelphia. p. 221-233
23. Chopp M., Zhang Z. G. Anti-adhesion molecule and nitric oxide protection strategies in ischemic stroke. Curr. Opin. Neurol. 91:1996;68-72
24. Ferro C. J., Webb D. J. Endothelial dysfunction and hypertension. Drugs. 53:1997;30-41
25. French J. F., Lambert L. E., Dage R. C. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Ther. 259:1991;260-264
26. Ialenti A., Ianaro A., Moncada S., Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:1992;177-182
27. Kolb H., Kolb-Bachofen V. Nitric oxide: A pathogenic factor in autoimmunity. Immunol. Today. 13:1992;157-160
28. Noel A. A., Fallek S. R., Hobson R. W. II, Duran W. N. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation. J. Vasc. Surg. 22:1995;661-669
29. Noel A. A., Hobson R. W. II, Duran W. N. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. Microvasc. Res. 52:1996;210-220
30. G-monomethyl-l-arginine. J. Exp. Med. 179:1994;651-660
31. Yamada R., Sartor R. B., Marshall S., Specian R. D., Grisham M. B. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology. 104:1993;759-771
32. Feng L. J., Price D. C., Mathes S. J., Hohn D. Dynamic properties of blood flow and leukocyte mobilization in infected flaps. World J. Surg. 14:1990;796-803
33. Mayrovitz H. N., Rubin R. Leukocyte distribution to arteriolar branches: Dependence on microvascular blood flow. Microvasc. Res. 29:1985;282-294
34. Ottaway C. A., Parrot D. M. Regional blood flow and its relationship to lymphocyte and lymphoblast traffic during a primary immune reaction. J. Exp. Med. 150:1979;218-230
35. Mulligan M. S., Hevel J. M., Marletta M. A., Ward P. A. Tissue injury caused by deposition of immune complexes is l-arginine dependent. Proc. Natl. Acad. Science USA. 88:1991;6338-6342
36. Storgard C. M., Stupack D. G., Jonczyk A., Goodman S. L., Fox R. I., Cheresh D. A. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J. Clin. Invest. 103:1999;47-54